Iridium(III) complexes are largely studied as anti-cancer complexes due to their excellent anti-cancer activity. In this article, two new iridium(III) complexes [Ir(piq)2(THPIP)]PF6 (THPIP = 2,4-di-tert-butyl-6-(1H-imidazo[4,5-f][1,10]phenanthrolin-2-yl)phenol, piq = deprotonated 1-phenylisoquinoline) (Ir1) and [Ir(bzq)2(THPIP)]PF6 (bzq = deprotonated benzo[h]quinolone) (Ir2) were synthesized. 3-(4
铱 (III) 配合物由于其出色的抗癌活性而被广泛研究为抗癌配合物。在本文中,两个新的
铱 (III) 配合物 [Ir(
PIq) 2 (TH
PIP)]PF 6 (TH
PIP = 2,4-di-tert-butyl-6-(1 H -imidazo[4,5-f] [1,10]phenanthrolin-2-yl)phenol,
PIq = deprotonated 1-phenylisoquinoline) ( Ir1 ) 和 [Ir(bzq) 2 (TH
PIP)]PF 6 (bzq = deprotonated benzo[ h ]quinolone) ( Ir2 )合成的。3-(
4,5-二甲基噻唑-2-基)-2,5-二苯基
四唑溴化物 (M
TT) 测定表明复合物Ir1表现出中等活性 (IC 50 = 29.9 ± 4.6 μM) 和Ir2 对 BEL-7402 细胞显示出高细胞毒性 (IC 50